In the BioHarmony Drug Report Database

"Preview" Icon

Moexipril

Univasc (moexipril) is a small molecule pharmaceutical. Moexipril was first approved as Univasc on 1995-04-19. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against angiotensin-converting enzyme.

 

Trade Name

 

Univasc
 

Common Name

 

moexipril
 

ChEMBL ID

 

CHEMBL1165
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Antihypertensives (ACE inhibitors)

Image (chem structure or protein)

Moexipril structure rendering